Coeptis Therapeutics Inc. Annual Selling and Marketing Expense in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Coeptis Therapeutics Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2021.
  • Coeptis Therapeutics Inc. Selling and Marketing Expense for the quarter ending September 30, 2022 was $2.86K.
  • Coeptis Therapeutics Inc. Selling and Marketing Expense for the twelve months ending September 30, 2022 was $6.91K, a 27.5% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Selling and Marketing Expense for 2021 was $2.92K, a 55.8% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $2.92K -$3.69K -55.8% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-11
2020 $6.61K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.